Report cover image

Novavax, Inc. - Strategy, SWOT and Corporate Finance Report

Publisher MarketLine
Published Dec 30, 2022
Length 52 Pages
SKU # MTLN17680742

Description

Novavax, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Novavax, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights
    Novavax Inc. (Novavax or 'the company') is a biotechnology company that discovers and develops vaccines for the prevention of serious infectious diseases. The company's major offerings include various vaccine candidates against respiratory syncytial virus (RSV), seasonal influenza, and the Ebola virus. Novavax markets vaccine candidates under Novavax, ResVax, Resolve, Prepare, Matrix, and NanoFlu brand names. It uses innovative proprietary recombinant nanoparticle vaccine technologies to develop various vaccines related to emerging disease threats. The company also develops various adjuvant formulations through proprietary Matrix technology. It operates manufacturing facilities in Gaithersburg, Maryland and Uppsala, Sweden. The company is headquartered in Gaithersburg, Maryland, the US.
Scope
  • Detailed information on Novavax, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Novavax, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Novavax, Inc. including a breakdown and examination of key business segments
  • Intelligence on Novavax, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Novavax, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
    • Reaasons to Buy
  • Gain understanding of Novavax, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Novavax, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Novavax, Inc.'s business structure, strategy and prospects.

Table of Contents

52 Pages
Company Snapshot
Novavax, Inc.: Company Overview
Novavax, Inc.: Overview and Key Facts
Novavax, Inc.: Overview
Novavax, Inc.: Key Facts
Novavax, Inc.: Key Employees
Novavax, Inc.: Key Employee Biographies
Novavax, Inc.: Major Products and Services
Novavax, Inc.: Company History
Novavax, Inc.: Management Statement
Novavax, Inc.: Locations and Subsidiaries
Novavax, Inc.: Key Competitors
Novavax, Inc.: Company Analysis
Novavax, Inc.: Business Description
Novavax, Inc.: SWOT Analysis
Novavax, Inc.: SWOT Overview
Novavax, Inc.: Strengths
Novavax, Inc.: Weaknesses
Novavax, Inc.: Opportunities
Novavax, Inc.: Threats
Novavax, Inc.: Corporate Financial Deals Activity
Novavax, Inc.: Financial Deals Overview
Novavax, Inc.: Targets and Partners
Novavax, Inc.: Top Deals 2018 - 2022YTD*
Novavax, Inc.: Advisors
Novavax, Inc.: Top Legal Advisors
Novavax, Inc.: Top Financial Advisors
Novavax, Inc.: Mergers and Acquisitions
Novavax, Inc.: Capital Raising
Novavax, Inc.: Partnership
Novavax, Inc.: Divestments
Novavax, Inc.: Private Equity and Ownership
Novavax, Inc.: Recent Developments
Novavax, Inc.: News and Events Summary
Novavax, Inc.: Corporate Governance
Novavax, Inc.: Financial Performance
Novavax, Inc.: Market Developments
Novavax, Inc.: Regulatory and Legal Events
Novavax, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Novavax, Inc.: Key Facts
Table 2: Novavax, Inc.: Key Employees
Table 3: Novavax, Inc.: Company History
Table 4: Novavax, Inc.: Locations and Subsidiaries
Table 5: Novavax, Inc.: Key Competitors
Table 6: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Novavax, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 8: Novavax, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Novavax, Inc.: Targets and Partners
Table 10: Novavax, Inc.: Top Deals 2018 - 2022YTD*
Table 11: Novavax, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Novavax, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Novavax, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Table 14: Novavax, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 15: Novavax, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 16: Novavax, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 17: Novavax, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 18: Novavax, Inc.: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 19: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022)
Table 20: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)
Table 21: Novavax, Inc.: News and Events Summary
Table 22: Novavax, Inc.: Corporate Governance
Table 23: Novavax, Inc.: Financial Performance
Table 24: Novavax, Inc.: Market Developments
Table 25: Novavax, Inc.: Regulatory and Legal Events
Table 26: Novavax, Inc.: Research & Development
List of Figures
Figure 1: CarMax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: CarMax, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: CarMax, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: CarMax, Inc.: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 5: CarMax, Inc.: M&A Activity by Geography (2018 - YTD*2022)
Figure 6: CarMax, Inc.: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 7: CarMax, Inc.: Corporate Venturing by Geography (2018 - YTD*2022)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us